Moleculera Labs and General Genomics Form Strategic Alliance to Utilize Proprietary AI to Provide Personalized Medicine for Autoimmune Neuropsychiatric Disorders
By AIT News Desk On Jul 26, 2022 Moleculera Labs, Inc. (Moleculera) and General Genomics, Inc. (GGI) announce the formation of a strategic alliance between the two companies. GGI will bring the power of multiple patent-pending healthcare machine learning (ML) and artificial intelligence (AI) innovations to direct individualized healthcare via their Curo46 Engine. Moleculera will […]
Personalizing Healthcare Through Data With General Genomics
by Ditsa Keren General Genomics is a bioinformatics artificial intelligence platform that provides customers with a comprehensive analysis of disease susceptibility and treatment effectiveness. In this interview, co-founders AJ Rosenthal and Warren Gieck discuss the importance of medical data ownership and its anticipated impact on personalized and preventative healthcare. Please describe the story behind the company: What sparked […]
